168 related articles for article (PubMed ID: 37151008)
21. [Incidence of benign and malignant lesions of eyelid and conjunctival tumors].
Obata H; Aoki Y; Kubota S; Kanai N; Tsuru T
Nippon Ganka Gakkai Zasshi; 2005 Sep; 109(9):573-9. PubMed ID: 16218435
[TBL] [Abstract][Full Text] [Related]
22. [Epidemiological and clinical characteristics of primary ocular cancers in blacks: our experience with 111 cases].
Seck SM; Agboton G; Gueye NN; Diop J; Seck CM; Lam A
J Fr Ophtalmol; 2015 Jan; 38(1):41-5. PubMed ID: 25530349
[TBL] [Abstract][Full Text] [Related]
23. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
24. [Prognosis of primary malignant tumors of the conjunctiva].
Chebbi A; Bouguila H; Boukari M; Lajmi H; Bouzain M; Abess I; Malek I; Mrad K; Zeghal I; Nacef L
J Fr Ophtalmol; 2015 Jun; 38(6):477-85. PubMed ID: 25976134
[TBL] [Abstract][Full Text] [Related]
25. Malignant conjunctival tumors invading the orbit.
Gökmen Soysal H; Ardiç F
Ophthalmologica; 2008; 222(5):338-43. PubMed ID: 18635931
[TBL] [Abstract][Full Text] [Related]
26. Therapy Failure and Resistance Mechanism in Eyelid and Ocular Surface Tumors.
Ju X; Gaca P; Fan W; Rokohl AC; Guo Y; Wawer Matos PA; Emmert S; Kakkassery V; Heindl LM
Neurosignals; 2022 Aug; 30(S1):21-38. PubMed ID: 36005157
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node biopsy in patients with conjunctival and eyelid cancers: experience in 17 patients.
Maalouf TJ; Dolivet G; Angioi KS; Leroux A; Genin P; George JL
Ophthalmic Plast Reconstr Surg; 2012; 28(1):30-4. PubMed ID: 22262287
[TBL] [Abstract][Full Text] [Related]
28. Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Malignancy: A Report by the American Academy of Ophthalmology.
Freitag SK; Aakalu VK; Tao JP; Wladis EJ; Foster JA; Sobel RK; Yen MT
Ophthalmology; 2020 Dec; 127(12):1757-1765. PubMed ID: 32698034
[TBL] [Abstract][Full Text] [Related]
29. [Retrospective study of thyroid invasion and central lymph node metastasis in 124 patients with hypopharyngeal carcinoma].
Liu HF; Huang ZG; Fang JG; Chen XH; Zhang Y; Hou LZ; Ma HZ; Guo W; Zhong Q
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Sep; 56(9):956-961. PubMed ID: 34666444
[No Abstract] [Full Text] [Related]
30. Clinical follow-up of conjunctival malignant melanoma.
Choi J; Kim M; Park HS; Lee SY
Korean J Ophthalmol; 2005 Jun; 19(2):91-5. PubMed ID: 15988922
[TBL] [Abstract][Full Text] [Related]
31. Conjunctival squamous cell carcinoma: prognostic factors for the recurrence and metastasis and clinicopathological characteristics at an oncological hospital in Peru.
Cruzado-Sanchez D; Tellez WA; Villarreal-Aguilar B; Melendez M; Olivera A; Moran F; Serpas-Frias S; Cordero-Garcia R
Br J Ophthalmol; 2020 Jul; 104(7):1010-1015. PubMed ID: 31604702
[TBL] [Abstract][Full Text] [Related]
32. Malignant eyelid tumours in Taiwan.
Wang JK; Liao SL; Jou JR; Lai PC; Kao SC; Hou PK; Chen MS
Eye (Lond); 2003 Mar; 17(2):216-20. PubMed ID: 12640409
[TBL] [Abstract][Full Text] [Related]
33. Clinical features predictive of orbital exenteration for conjunctival melanoma.
Shields JA; Shields CL; Gündüz K; Cater J
Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):173-8. PubMed ID: 10826757
[TBL] [Abstract][Full Text] [Related]
34. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
35. Profile of eyelid malignancy in a Tertiary Health Care Center in North India.
Gupta P; Gupta RC; Khan L
J Cancer Res Ther; 2017; 13(3):484-486. PubMed ID: 28862213
[TBL] [Abstract][Full Text] [Related]
36. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
[TBL] [Abstract][Full Text] [Related]
37. Subtotal Exenteration of the Orbit for Benign Orbital Disease.
Furdova A; Babal P; Zahorjanova P; Sekac J
J Craniofac Surg; 2020; 31(5):1367-1369. PubMed ID: 32224777
[TBL] [Abstract][Full Text] [Related]
38. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy.
Tuomaala S; Kivelä T
Ophthalmology; 2004 Apr; 111(4):816-21. PubMed ID: 15051218
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
40. Risk factors and prognosis of orbital exenteration in conjunctival melanoma.
Zong C; Jia S; Zhu T; Shi H; Tian H; Li Y; Jia R; Xu S
Eye (Lond); 2023 Aug; 37(11):2272-2280. PubMed ID: 36522530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
